AAAAAA

   
Results: 1-20 |
Results: 20
Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis
Authors: Iozzo, P Pratipanawatr, T Pijl, H Vogt, C Kumar, V Pipek, R Matsuda, M Mandarino, LJ Cusi, KJ DeFronzo, RA
Citation: P. Iozzo et al., Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis, AM J P-ENDO, 280(5), 2001, pp. E712-E719
Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone
Authors: Miyazaki, Y Mahankali, A Matsuda, M Glass, L Mahankali, S Ferrannini, E Cusi, K Mandarino, LJ DeFronzo, RA
Citation: Y. Miyazaki et al., Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone, DIABET CARE, 24(4), 2001, pp. 710-719
Exercise increases hexokinase II mRNA, but not activity in obesity and type 2 diabetes
Authors: Cusi, KJ Pratipanawatr, T Koval, J Printz, R Ardehali, H Granner, DK DeFronzo, RA Mandarino, LJ
Citation: Kj. Cusi et al., Exercise increases hexokinase II mRNA, but not activity in obesity and type 2 diabetes, METABOLISM, 50(5), 2001, pp. 602-606
Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes
Authors: Cusi, K Cukier, S DeFronzo, RA Torres, M Puchulu, FM Redondo, JCP
Citation: K. Cusi et al., Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes, J CLIN END, 86(3), 2001, pp. 1410-1417
Skeletal muscle insulin resistance in normoglycemic subjects with a strongfamily history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation
Authors: Pratipanawatr, W Pratipanawatr, T Cusi, K Berria, R Adams, JM Jenkinson, CP Maezono, K DeFronzo, RA Mandarino, LJ
Citation: W. Pratipanawatr et al., Skeletal muscle insulin resistance in normoglycemic subjects with a strongfamily history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation, DIABETES, 50(11), 2001, pp. 2572-2578
Bromocriptine - A novel approach to the treatment of type 2 diabetes
Authors: Pijl, H Ohashi, S Matsuda, M Miyazaki, Y Mahankali, A Kumar, V Pipek, R Iozzo, P Lancaster, JL Cincotta, AH DeFronzo, RA
Citation: H. Pijl et al., Bromocriptine - A novel approach to the treatment of type 2 diabetes, DIABET CARE, 23(8), 2000, pp. 1154-1161
An equation for insulin sensitivity index - Response
Authors: DeFronzo, RA
Citation: Ra. Defronzo, An equation for insulin sensitivity index - Response, DIABET CARE, 23(5), 2000, pp. 712-712
Insulin sensitivity indexes calculated from oral glucose tolerance test data - Response
Authors: Matsuda, M DeFronzo, RA
Citation: M. Matsuda et Ra. Defronzo, Insulin sensitivity indexes calculated from oral glucose tolerance test data - Response, DIABET CARE, 23(10), 2000, pp. 1595-1596
Report of the Expert Committee on the diagnosis and classification of diabetes mellitus
Authors: Gavin, JR Alberti, KGMM Davidson, MB DeFronzo, RA Drash, A Gabbe, SG Genuth, S Harris, MI Kahn, R Keen, H Knowler, WC Lebovitz, H Maclaren, NK Palmer, JP Raskin, P Rizza, RA Stern, MP
Citation: Jr. Gavin et al., Report of the Expert Committee on the diagnosis and classification of diabetes mellitus, DIABET CARE, 23, 2000, pp. S4-S19
Diabetic nephrology
Authors: Molitch, ME DeFronzo, RA Franz, MJ Keane, WF Mogensen, CE Parving, HH Steffes, MW
Citation: Me. Molitch et al., Diabetic nephrology, DIABET CARE, 23, 2000, pp. S69-S72
Insulin resistance differentially affects the PI3-kinase- and MAP kinase-mediated signaling in human muscle
Authors: Cusi, K Maezono, K Osman, A Pendergrass, M Patti, ME Pratipanawatr, T DeFronzo, RA Kahn, CR Mandarino, LJ
Citation: K. Cusi et al., Insulin resistance differentially affects the PI3-kinase- and MAP kinase-mediated signaling in human muscle, J CLIN INV, 105(3), 2000, pp. 311-320
Pharmacologic therapy for type 2 diabetes mellitus
Authors: DeFronzo, RA
Citation: Ra. Defronzo, Pharmacologic therapy for type 2 diabetes mellitus, ANN INT MED, 133(1), 2000, pp. 73-74
Effects of exercise and insulin on insulin signaling proteins in human skeletal muscle
Authors: Koval, JA Maezono, K Patti, ME Pendergrass, M DeFronzo, RA Mandarino, LJ
Citation: Ja. Koval et al., Effects of exercise and insulin on insulin signaling proteins in human skeletal muscle, MED SCI SPT, 31(7), 1999, pp. 998-1004
Insulin sensitivity indices obtained from oral glucose tolerance testing -Comparison with the euglycemic insulin clamp
Authors: Matsuda, M DeFronzo, RA
Citation: M. Matsuda et Ra. Defronzo, Insulin sensitivity indices obtained from oral glucose tolerance testing -Comparison with the euglycemic insulin clamp, DIABET CARE, 22(9), 1999, pp. 1462-1470
Report of the expert committee on the diagnosis and classification of diabetes mellitus
Authors: Gavin, JR Alberti, KGMM Davidson, MB DeFronzo, RA Drash, A Gabbe, SG Genuth, S Harris, MI Kahn, R Keen, H Knowler, WC Lebovitz, H Maclaren, NK Palmer, JP Raskin, P Rizza, RA Stern, MP
Citation: Jr. Gavin et al., Report of the expert committee on the diagnosis and classification of diabetes mellitus, DIABET CARE, 22, 1999, pp. S5-S19
Synergistic interaction of magnesium and vanadate on glucose metabolism indiabetic rats
Authors: Matsuda, M Mandarino, L DeFronzo, RA
Citation: M. Matsuda et al., Synergistic interaction of magnesium and vanadate on glucose metabolism indiabetic rats, METABOLISM, 48(6), 1999, pp. 725-731
Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemiain conscious normal rats
Authors: Koopmans, SJ Kushwaha, RS DeFronzo, RA
Citation: Sj. Koopmans et al., Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemiain conscious normal rats, METABOLISM, 48(3), 1999, pp. 330-337
Pathogenesis of type 2 diabetes - Implications for metformin
Authors: DeFronzo, RA
Citation: Ra. Defronzo, Pathogenesis of type 2 diabetes - Implications for metformin, DRUGS, 58, 1999, pp. 29-30
Altered hypothalamic function in response to glucose ingestion in obese humans
Authors: Matsuda, M Liu, YJ Mahankali, S Pu, YL Mahankali, A Wang, J DeFronzo, RA Fox, PT Gao, JH
Citation: M. Matsuda et al., Altered hypothalamic function in response to glucose ingestion in obese humans, DIABETES, 48(9), 1999, pp. 1801-1806
Pharmacologic therapy for type 2 diabetes mellitus
Authors: DeFronzo, RA
Citation: Ra. Defronzo, Pharmacologic therapy for type 2 diabetes mellitus, ANN INT MED, 131(4), 1999, pp. 281-303
Risultati: 1-20 |